Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_assertion description "[Also apolipoproteins show major changes, with an increase in apolipoprotein A-I, A-IV, B, C, and E. Particularly the changes in apo C-II, which is an activator of the enzyme lipoprotein lipase (LPL), and apo C-III, an inhibitor of LPL, with an increase of the C-III to C-II ratio, might contribute to the impaired lipoprotein catabolism in NS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_assertion evidence source_evidence_literature NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_assertion SIO_000772 15827892 NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_assertion wasDerivedFrom befree-20140225 NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_assertion wasGeneratedBy ECO_0000203 NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP682300.RARYKPaSaXajnFBCeCNCJXfs9osLJhd26AxoRaUZG8YS8130_provenance.